George Elston | Chief Financial Officer |
Nancy Lurker | President and CEO |
Jay Duker | Chief Strategic Scientific Officer |
Scott Jones | Chief Commercial Officer |
Dario Paggiarino | Senior Vice President and CMO |
Andrew D'Silva | B. Riley |
Good morning. My name is Bridget, and I’ll be your conference operator today. At this time, I would like to welcome everyone to the EyePoint Pharmaceuticals Third Quarter 2020 Financial Results Conference Call. There will be a question-and-answer session to follow at the completion of the prepared remarks. Please be advised that this call is being recorded at the company’s request.